Description

Benzamide, 4-(Aminosulfonyl)-n-(6-Amino-1,2,3,4-Tetrahydro-2,4-Dioxo-1,3-Dipropyl-5-Pyrimidinyl)- is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is of significant commercial importance for its role in the synthesis of specialized active pharmaceutical ingredients (APIs). It is primarily required by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing novel therapeutic agents.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of proprietary drug candidates, particularly in therapeutic areas requiring complex molecular architectures.
• Research & Development: Used in medicinal chemistry for structure-activity relationship (SAR) studies and the development of new chemical entities.
• API Synthesis: Serves as a critical precursor in multi-step synthetic routes for producing target active pharmaceutical ingredients.
• Biochemical Research: Potential use as a tool compound or inhibitor in biochemical assays and pharmacological studies.
• Fine Chemical Production: Employed in the custom synthesis of high-value, low-volume specialty chemicals for advanced applications.

Basic Information

Product Name	Benzamide, 4-(Aminosulfonyl)-n-(6-Amino-1,2,3,4-Tetrahydro-2,4-Dioxo-1,3-Dipropyl-5-Pyrimidinyl)-
CAS No.	102613-61-6
Molecular Formula	C17H24N6O5S
Molecular Weight	424.48 g/mol
Synonyms	4-(Aminosulfonyl)-N-[6-amino-1,3-dipropyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl]benzamide; 1,3-Dipropyl-6-amino-5-[[(4-sulfamoyl)benzoyl]amino]uracil; 5-[[(4-Aminosulfonyl)benzoyl]amino]-1,3-dipropyl-6-aminouracil; 1,3-Dipropyl-6-amino-5-[(4-sulfamoylbenzoyl)amino]uracil; Benzamide, 4-(aminosulfonyl)-N-[6-amino-1,3-dipropyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl]-; 102613-61-6; A-802715 (research code)
EINECS	Contact for details

Quality Control

Our production of this high-value intermediate adheres to strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the exacting standards required for pharmaceutical development. Certificates of Analysis (COA) with full traceability are provided for each lot. We support development projects with custom purity specifications and can align with cGMP guidelines as required.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at controlled room temperature (15-25°C). The compound may be hygroscopic; keep the container tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Related Substances (HPLC)	Individual impurity ≤ 0.5%, Total impurities ≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.